Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating diabetic retinopathy using anti-ceramide monoclonal antibody 2A2

Methods for treating diabetic retinopathy using anti-ceramide monoclonal antibody 2A2

US Patent 10975169 · Granted Apr 13, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Perfusion modulated tumor dose sculpting with single dose radiotherapy2025
Methods for treating GI syndrome and graft versus host disease2024
Enhancement of tumor response to chemotherapy by activation of the asmase/cerami2024
Anti-ceramide antibodies2022
Enhancement of tumor response to chemotherapy by activation of the asmase/cerami2022
Methods for treating GI syndrome and graft versus host disease2021
Methods for treating GI syndrome and graft versus host disease2020
Anti-ceramide antibodies2019
Enhancement of tumor response to chemotherapy by activation of the ASMase/cerami2019
Ceramide reversal of multi-drug resistance2018
Anti-ceramide monoclonal antibody 2A22017
Methods for treating GI syndrome and graft versus host disease2013